Recruiting PHASE2, PHASE3 Pain Management

New treatment option for Pain Management

Official title Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block

ClinicalTrials.gov ID: NCT06899841

What this study is testing

What is Dexmedetomidine?

Dexmedetomidine is an investigational medicine, being studied as a potential treatment for pain management.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.
  • Phase 3: a large, late-stage study

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 70

You may be able to join if

  • Age between 18 and 70 years.
  • Both sexes, males and females.
  • Patients with the American Society of Anesthesiologists (ASA) physical status I/II.
  • Body mass index (BMI) of 18-35 kg/m2
  • Patients scheduled for elective Renal or Percutaneous Nephrolithotomy.

You likely can't join if

  • Patients under 18 years.
  • Patient refusal of nerve block.
  • Infection at the site of injection.
  • Coagulopathy.
  • Allergy to used medications.
  • Psychiatric disorder or chronic pain syndromes.
See the full eligibility criteria
Who can join
  • Age between 18 and 70 years.
  • Both sexes, males and females.
  • Patients with the American Society of Anesthesiologists (ASA) physical status I/II.
  • Body mass index (BMI) of 18-35 kg/m2
  • Patients scheduled for elective Renal or Percutaneous Nephrolithotomy.
What rules you out
  • Patients under 18 years.
  • Patient refusal of nerve block.
  • Infection at the site of injection.
  • Coagulopathy.
  • Allergy to used medications.
  • Psychiatric disorder or chronic pain syndromes.
  • Chronic opioid use or substance abuse.
  • Quadriplegic patients.

The study team makes the final eligibility decision.

Where it's taking place

  • Asyut, Assiut Governorate, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Asyut, Assiut Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.